-
Homoharringtonine: From Ribosome to Translation
2026-08-13
A translational perspective on Homoharringtonine as a cytotoxic alkaloid for leukemia research, cancer biology, and emerging SARS-CoV-2 antiviral research, with mechanistic context, validation strategy, and practical workflow guidance.
-
EdU Imaging Kits (488): 5 Lab Scenarios
2026-08-13
Discover how EdU Imaging Kits (488), SKU K1175, address common challenges in S-phase DNA synthesis measurement, multiplex imaging, protocol optimization, and cytotoxicity interpretation. This scenario-based guide connects click chemistry DNA synthesis detection with practical decisions for reliable cell proliferation assays.
-
Myriocin: SPT Inhibition as a Metabolic Probe
2026-08-12
Myriocin is a potent serine palmitoyltransferase inhibitor that enables causal studies of sphingolipid metabolism, cancer biology, and immune signaling. This article connects its pathway-level precision with a recent multiscale yeast aging study to improve assay design and interpretation.
-
Recombinant Mouse Macrophage Colony Stimulating Factor
2026-08-12
Build a controlled macrophage baseline for fibrosis, osteoclast, cancer, and inflammatory assays with a defined mouse cytokine input. This workflow connects M-CSF-driven cell preparation to the IGF2BP1–THBS1–TLR4 findings reported in pulmonary fibrosis research while separating differentiation effects from disease-specific signaling.
-
Actinomycin D Workflows for RNA Stability Studies
2026-08-11
Actinomycin D, or ActD, turns transcriptional shutoff into a practical way to measure mRNA decay, transcriptional stress, and apoptosis induction. This workflow-oriented guide shows how to apply it to cancer research and PVT1–HIF-1α pathway studies while avoiding dosing, solubility, and interpretation errors.
-
VE-821 ATR Kinase Inhibitor: Assay Guide
2026-08-11
A scenario-based guide to using VE-821 for cell-viability, DNA damage response, radiosensitization, and combination-treatment assays. It explains how SKU A2521 supports reproducible experimental design through defined potency, DMSO handling, storage, and interpretation guidance.
-
CHIR-99021 (CT99021) Stem Cell Workflow Guide
2026-08-10
Learn how to use CHIR-99021 (CT99021) to tune GSK-3 activity across pluripotency, lineage differentiation, and WNT-responsive degradation assays. This guide combines a practical dosing workflow with reference-informed assay design and troubleshooting for more interpretable stem cell data.
-
Myriocin Workflows for Sphingolipid Research
2026-08-09
Build cleaner sphingolipid experiments with Myriocin, a selective serine palmitoyltransferase inhibitor suited to target-engagement, lipid, apoptosis, and proliferation assays. This workflow connects mechanistic SPT inhibition with cardiomyocyte injury, cancer research, and immunosuppressive studies while emphasizing controls, timing, and troubleshooting.
-
ARCA EGFP mRNA (5-moUTP): Translational Control
2026-08-08
A mechanism-driven guide to using ARCA EGFP mRNA (5-moUTP) as a fluorescence-based transfection control, with practical advice for separating delivery performance, transcript quality, cellular stress, and translational readiness.
-
Minoxidil sulphate: A Renal Assay Decision Guide
2026-08-07
Minoxidil sulphate is a versatile potassium-channel research tool. This guide explains how renal perfusion models, sepsis timing, blocker selection, and endpoint choice reshape interpretation of vascular assays.
-
Resazurin Cell Viability Assay Kit: Precision & Sensitivity
2026-08-07
The Resazurin Cell Viability Assay Kit enables ultra-sensitive, non-toxic quantification of live cells in high-throughput workflows. This article benchmarks its performance, details mechanism, and clarifies optimal deployment for researchers seeking reliable cell viability assays.
-
Açaí Extracts: Cytotoxicity and Hepatocyte Enzyme Induction
2026-08-06
Raichura et al. conducted a comprehensive in vitro investigation of açaí (Euterpe oleracea) extracts, examining their cytotoxic effects and potential to induce key drug-metabolizing enzymes and transporters in human hepatocytes. The study found dose-dependent cytotoxicity with certain extracts but minimal induction of CYP450s or major transporters, informing the safety and drug-interaction risk profile of botanical supplements.
-
EPZ-6438: Transforming EZH2 Inhibition in Translational Onco
2026-08-06
EPZ-6438, a potent and selective EZH2 inhibitor, is redefining epigenetic cancer research by enabling precise interrogation of the polycomb repressive complex 2 (PRC2) pathway. This thought-leadership article provides translational researchers with mechanistic insights, protocol parameters, and strategic guidance. Drawing from recent studies, including combinatorial approaches in melanoma and advanced tumor models, it offers a roadmap for leveraging EPZ-6438 to accelerate discovery, overcome resistance, and translate molecular findings into clinical innovation.
-
Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol on Hepatic Stel
2026-08-05
This study identifies 1-Phenyl-2-Pentanol (1-PHE) from Moringa oleifera as a potent modulator of hepatic stellate cell activation. By targeting fibrogenic signaling pathways, 1-PHE demonstrates significant in vitro anti-fibrotic activity, indicating promising utility for liver fibrosis and metabolic disease research.
-
β-Elemene Inhibits Adipogenesis via AMPK Activation in 3T3-L
2026-08-05
This study elucidates how β-Elemene suppresses lipid accumulation and reverses insulin resistance in 3T3-L1 cells by activating the AMPK pathway. The findings provide mechanistic evidence positioning β-Elemene as a valuable research tool for investigating adipogenesis and metabolic regulation.